You have read all your free articles, to continue reading subscribe to read the rest of this content.
SmartCella Holding has announced the raising to further advance and accelerate the development of core technologies in the company’s three business units, Procella Therapeutics, Smartwise and SvedMed Solutions. The financing, led by advisor SEB, brings together a renowned group of investors witAlready a subscriber Login You have read all your…
The Swedish medtech company has signed Azaris Medical Equipment to introduce Bactiguard's portfolio for Infection control in Ukraine. The portfolio includes urinary, intravenous and respiratory catheters. "Healthcare Acquired Infections (HAI) is a global problem and with our unique solution,Already a subscriber Login You have read all your free articles, to…
Hansa Biopharma has announced that its treatment Idefirix is, as of August 1, reimbursable and available for use in the Netherlands. Idefirix is the first and only treatment approved for use in the European Union for desensitization of highly sensitized patients prior to kidney transplantation, aAlready a subscriber Login You…
Novo Nordisk has announced that the Japanese Ministry of Health, Labour and Welfare has approved Rybelsus (oral semaglutide), the first and only oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) in a tablet, for the treatment of adults with type 2 diabetes. The approval of Rybelsus in JapaAlready a subscriber Login…
